Neovasc Inc. SG&A Expenses

SG&A Expenses of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including SG&A Expenses growth rates and interactive chart. Selling, general and administrative expense (SG&A) is reported on the income statement as the sum of all direct and indirect selling expenses and all general and administrative expenses (G&A) of a company. SG&A, also known as SGA, includes all the costs not directly tied to making a product or performing a service. That is, SG&A includes the costs to sell and deliver products and services and the costs to manage the company. It includes administrative


Highlights and Quick Summary

  • SG&A Expenses for the quarter ending March 31, 2022 was $3.82 Million (a 85.49% increase compared to previous quarter)
  • Year-over-year quarterly SG&A Expenses decreased by -15.14%
  • Annual SG&A Expenses for 2021 was $17.7 Million (a 8.51% increase from previous year)
  • Annual SG&A Expenses for 2020 was $16.3 Million (a 49.27% increase from previous year)
  • Annual SG&A Expenses for 2019 was $10.9 Million (a 1.19% increase from previous year)
  • Twelve month SG&A Expenses ending March 31, 2022 was $13.8 Million (a -12.87% decrease compared to previous quarter)
  • Twelve month trailing SG&A Expenses decreased by -28.03% year-over-year
Trailing SG&A Expenses for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$13.8 Million $15.8 Million $17.4 Million $19.2 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical SG&A Expenses of Neovasc Inc.

Most recent SG&A Expensesof NVCN including historical data for past 10 years.

Interactive Chart of SG&A Expenses of Neovasc Inc.

Neovasc Inc. SG&A Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $3.82
2021 $2.06 $3.41 $4.5 $5.86 $17.65
2020 $3.66 $5.14 $4.28 $3.04 $16.27
2019 $3.17 $2.58 $2.86 $3.05 $10.9
2018 $6.03 $6.54 $2.46 $2.76 $10.77
2017 $8.54 $2.12 $2.48 $3.44 $14.61
2016 $2.6 $3.68 $7.61 $5.99 $19.88
2015 $3.78 $4.67 $3.66 $2.45 $14.57
2014 $2.9 $2.69 $4.28 $1.01 $10.88
2013 $1.15 $0.97 $0.93 $1.73 $4.78
2012 $0.91 $0.98 $0.98 $1.25 $4.12
2011 $3.32

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.